Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implicationsCOVID-19 대유행 기간 동안 편두통 환자에서 항-CGRP 단일클론항체의 안전성: 현재 및 미래 의미Article Published on 2021-10-012022-09-12 Journal: Neurología (Barcelona, Spain) [Category] MERS, SARS, 진단, [키워드] age analyzed antagonist Anticuerpos monoclonales association caused CGRP Characteristics Clinical practice collected data condition conducted coronavirus coronavirus SARS-CoV-2 COVID-19 COVID-19 pandemic COVID-19 symptom cross-sectional Diagnostic Criteria English group headache hospitalised immunological implication increased risk involved mAb media migraine Migraña monoclonal antibodies monoclonal antibody multicentre National NEUROLOGY Pandemia pathophysiology Patient patients with COVID-19 present presenting receiving recruited Respiratory system Safe Safety SARS-CoV-2 Sepsis severity Society Spanish Standard deviation statistically significant difference Symptoms the patient the SARS-CoV-2 treated Treatment with COVID-19 women [DOI] 10.1016/j.nrleng.2021.03.005 PMC 바로가기 [Article Type] Article
Patients with schizophrenia have decreased COVID-19 prevalence among hospitalised patients with psychiatric and neurological diseases: A retrospective analysis in Mexican population정신 분열증 환자는 정신과 및 신경계 질환으로 입원한 환자들 사이에서 COVID-19 유병률을 감소시켰습니다: 멕시코 인구에 대한 후향적 분석Article Published on 2021-10-012022-09-11 Journal: International journal of clinical practice [Category] SARS, 치료기술, [키워드] 95% CI age analysed average Comorbidities coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic diagnoses Diagnosis disorder Effect First wave Gender General population hospital hospitalised hospitalised patient Hospitalised patients incidence Increased increased risk intellectual disability lower mortality medical diagnosis Mortality mortality rate National neurologic neurologic disorder neurologic disorders neurological Neurological disorder Neurological disorders Odds ratios Patient patients with comorbidities patients with comorbidity patients with COVID-19 predisposition Prevalence prevalence of COVID-19 Psychiatric psychiatric disorder Psychiatric disorders Psychiatric Hospital reported Retrospective analysis Schizophrenia Variation [DOI] 10.1111/ijcp.14528 PMC 바로가기 [Article Type] Article
Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated CoagulopathyArticle Published on 2021-09-302022-10-29 Journal: International Review of Cell and Molecular Biology [Category] COVID-19, [키워드] 95% CI 95% confidence interval anticoagulant therapy Blood coagulation Coagulopathy contribute Controlled trial Coronavirus infection Course current death dose Effect effective enoxaparin enrolled exacerbate heparin hospitalised include increased mortality increased risk intensive care intubation intubation rate LMWH Mortality multivariate logistic regression no significant difference Odds ratio Patient patients treated Prophylactic prophylactic dose prophylactic doses randomised recommendation reducing Respiratory failure risk Risk factors SARS-CoV-2 severe COVID-19 therapeutic therapeutic dose therapeutic doses Treatment unfractionated heparin [DOI] 10.3390/life11101032 PMC 바로가기 [Article Type] Article
Prevalence and Course of SARS-CoV-2 Infection among Immunocompromised Children Hospitalised in the Tertiary Referral Hospital in PolandArticle Published on 2021-09-302022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] Alter analysed Analysis Asymptomatic biochemical both groups Cancer children Clinical characteristics Clinical data comparable Course COVID-19 diagnosed with COVID-19 disease feature fevers Gastrointestinal infection Haemoglobin hospitalised immunodeficiency Infection Laboratory liver transplant lymphocyte counts Mild mild clinical symptom not differ paediatric population Patient Poland positive Prevalence Referral reported symptom response Retrospective study SARS-CoV-2 SARS-COV-2 infection Seven study group subgroup Tertiary tertiary referral hospital tested Treatment underlying diseases urea variables Warsaw was performed White blood cell [DOI] 10.3390/jcm10194556 PMC 바로가기 [Article Type] Article
Characterising long COVID: a living systematic reviewOriginal Research Published on 2021-09-272022-10-28 Journal: BMJ Global Health [Category] COVID-19, SARS, [키워드] 95% CI acute COVID-19 aetiology analysed Biomarker breathlessness Characteristics children CINAHL Clinical management clinically suspected Cohort complex Concentration country COVID COVID-19 cross-sectional database Evidence fatigue female follow-up time Frequency global health Google Scholar help heterogeneous hospitalised Hoy impairment IMPROVE Long malaise Meta-analysis moderate MOST outcomes over OVID Patient physical Population Prevalence produced Psychological public health Pulmonary function reduced rehabilitation reported Result risk risk factor Risk of bias robust searched Symptom Symptoms systematic review weakness while WHO [DOI] 10.1136/bmjgh-2021-005427 PMC 바로가기 [Article Type] Original Research
Lung function and breathing patterns in hospitalised COVID-19 survivors: a review of post-COVID-19 Clinics입원 CovID-19 생존자의 폐 기능 및 호흡 패턴 : Covid-19 Clinics의 검토Research Published on 2021-09-272022-09-01 Journal: Respiratory Research [Category] 진단, [키워드] A p-value abnormality alveolar volume appear category changes Chi-squared test Continuous Continuous data COVID-19 Critical Care and Emergency Medicine determine detrimental discharge distribution Effect Evidence evidence of explained fatigue Fisher’s exact test groups hospital discharge hospitalised independent t-test Infectious disease Intensive Interstitial lung disease lung damage Lung function majority mechanical ventilation Muscle fatigue obesity oxygen P-value Patient patients reduced reduced vital capacity respiratory respiratory muscle Respiratory Physiology Result severity of COVID-19 spirometry statistically significant subjects supplemental oxygen Survivors therapy transfer transfer factor Treatment Ventilation vital capacity were measured [DOI] 10.1186/s12931-021-01834-5 PMC 바로가기 [Article Type] Research
Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory SignalsArticle Published on 2021-09-272022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] alanine aminotransferase Analysis assessment Causality Characteristics clinical manifestations Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 daily dose defined demonstrated drug drug induced liver injury (DILI) Drug-induced liver injury drugs Hepatitis hepatocellular hepatotoxic highest hospital hospitalised Hydroxychloroquine immune mechanism incidence incidence rate Laboratory limit Liver damage lymphocyte transformation lymphocyte transformation test (LTT) marker mechanism Mild Patient patients performed pharmacovigilance positive Program Remdesivir severity signal Spain subsequent recovery subset Tocilizumab treated university updated Roussel Uclaf Causality Assessment Method (RUCAM) was performed with COVID-19 [DOI] 10.3390/jcm10194432 PMC 바로가기 [Article Type] Article
Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional StudyPublic Health Published on 2021-09-242022-10-31 Journal: Frontiers in Public Health [Category] COVID-19, MERS, SARS, [키워드] Admission age Analysis association Barcelona Comorbidity COVID-19 cross-sectional analysis death defined evaluated events Hospital admission hospitalisation hospitalised IMV In-hospital invasive mechanic ventilation Invasive mechanical ventilation Logistic regression analysis Mortality observation period Older outcome performed Primary outcome receiving risk factor significantly Spain study outcome subject Treatment Vitamin D Vitamin D supplementation [DOI] 10.3389/fpubh.2021.758347 PMC 바로가기 [Article Type] Public Health
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)Interstitial Lung Disease Published on 2021-09-232022-10-28 Journal: BMJ Open Respiratory Research [Category] COVID-19, [키워드] alveolar Analysis approvals assessment biochemical breathlessness Bronchoalveolar lavage bronchoscopy clinically Community consequence COVID COVID-19 COVID-19 pandemic deaths determine dissemination dysfunction Epigenetic Ethics exploratory Factor fatigue Gene Expression Genetic Hospital admission hospitalised ILD include indicated Infection interstitial Interstitial Fibrosis Interstitial lung disease lung mitigate MRI observational study Patient patients with COVID-19 peer-reviewed platform Prevalence progression Result RNA Secondary objective Severe infection severity Single Cell Symptoms trajectory transfer understanding Whole blood xenon [DOI] 10.1136/bmjresp-2021-001049 PMC 바로가기 [Article Type] Interstitial Lung Disease
Robots in Healthcare? What Patients SayArticle Published on 2021-09-212022-10-29 Journal: International Journal of Environmental Research an [Category] Coronavirus, SARS, [키워드] Analysis approach artificial intelligence Attending Care care crisis COVID-19 develop dominant Effect ethics of care explain health system healthcare hospitalised interpretative repertoires lack pandemic patients’ perspectives Perspective resources respond robot robots science and technology studies Variability [DOI] 10.3390/ijerph18189933 PMC 바로가기 [Article Type] Article